Novel sorbents for removal of gadolinium-based contrast agents in sorbent dialysis and hemoperfusion: preventive approaches to nephrogenic systemic fibrosis.
about
Basic MR relaxation mechanisms and contrast agent designFunctional sorbents for selective capture of plutonium, americium, uranium, and thorium in bloodNanoporous sorbent material as an oral phosphate binder and for aqueous phosphate, chromate, and arsenate removalFunctionalized nanoporous silica for the removal of heavy metals from biological systems: adsorption and applicationNovel oral detoxification of mercury, cadmium, and lead with thiol-modified nanoporous silicaThe Role of Ligand Topology in the Decomplexation of Luminescent Lanthanide Complexes by Dipicolinic Acid.Low risk for nephrogenic systemic fibrosis in nondialysis patients who have chronic kidney disease and are investigated with gadolinium-enhanced magnetic resonance imaging.Selective capture of cesium and thallium from natural waters and simulated wastes with copper ferrocyanide functionalized mesoporous silica.Improving T₁ and T₂ magnetic resonance imaging contrast agents through the conjugation of an esteramide dendrimer to high-water-coordination Gd(III) hydroxypyridinone complexes.Silica microparticles as a solid support for gadolinium phosphonate magnetic resonance imaging contrast agents.Analysis of Lanthanide Complex Dendrimer Conjugates for Bimodal NIR and MRI Imaging.Nanoporous biomaterials for uremic toxin adsorption in artificial kidney systems: A review.Removal of gadolinium-based contrast agents: adsorption on activated carbon.
P2860
Q27692546-2E6D0C36-ACF2-42D2-B89E-B800F414B16CQ28382820-641FB259-EDD2-4B2A-BBA0-9F648A6B3092Q28385247-FD5E2AD1-5070-4304-8897-07D6EF055DEBQ28387911-15C98ABC-81F0-40A3-B88C-80027764CA18Q28658195-41534E10-12AC-40AA-9599-0EA4073FBA82Q31122387-F6C00541-4277-499D-B10A-C83EE0564D3CQ33684026-AF257A56-671D-4AD7-99F0-85101B9E517AQ34069126-08FAFD36-4929-439A-B45C-5F4F9D5C41F4Q34161701-0DFEF636-9E3B-4FB1-8092-C12A6AB99CDFQ36112041-57F9A97F-0BA7-4A3D-B895-55D4E5ED3860Q36443368-11977C5C-6D37-418F-9A0F-EBE2ECEF765BQ38749426-F69F877E-A82E-4A9D-A813-DE7F6956E864Q47990021-7C697E7E-A209-4B7C-B839-B487C43D9FE6
P2860
Novel sorbents for removal of gadolinium-based contrast agents in sorbent dialysis and hemoperfusion: preventive approaches to nephrogenic systemic fibrosis.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Novel sorbents for removal of ...... nephrogenic systemic fibrosis.
@ast
Novel sorbents for removal of ...... nephrogenic systemic fibrosis.
@en
type
label
Novel sorbents for removal of ...... nephrogenic systemic fibrosis.
@ast
Novel sorbents for removal of ...... nephrogenic systemic fibrosis.
@en
prefLabel
Novel sorbents for removal of ...... nephrogenic systemic fibrosis.
@ast
Novel sorbents for removal of ...... nephrogenic systemic fibrosis.
@en
P2093
P2860
P1476
Novel sorbents for removal of ...... nephrogenic systemic fibrosis.
@en
P2093
George A Porter
Glen E Fryxell
Kanda Pattamakomsan
Kenneth N Raymond
Vichaya Sukwarotwat
View Koonsiripaiboon
Wassana Yantasee
Wilaiwan Chouyyok
P2860
P356
10.1016/J.NANO.2009.05.002
P577
2009-05-15T00:00:00Z